170 related articles for article (PubMed ID: 17456483)
1. Trimetazidine improves endothelial dysfunction in chronic heart failure: an antioxidant effect.
Belardinelli R; Solenghi M; Volpe L; Purcaro A
Eur Heart J; 2007 May; 28(9):1102-8. PubMed ID: 17456483
[TBL] [Abstract][Full Text] [Related]
2. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
Belardinelli R; Lacalaprice F; Faccenda E; Volpe L
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):533-40. PubMed ID: 18797405
[TBL] [Abstract][Full Text] [Related]
3. Improvement of peripheral endothelial dysfunction by acute vitamin C application: different effects in patients with coronary artery disease, ischemic, and dilated cardiomyopathy.
Erbs S; Gielen S; Linke A; Möbius-Winkler S; Adams V; Baither Y; Schuler G; Hambrecht R
Am Heart J; 2003 Aug; 146(2):280-5. PubMed ID: 12891196
[TBL] [Abstract][Full Text] [Related]
4. The effects of trimetazidine on heart rate variability in patients with slow coronary artery flow.
Topal E; Ozdemir R; Barutcu I; Aksoy Y; Sincer I; Akturk E; Cehreli S
J Electrocardiol; 2006 Apr; 39(2):211-8. PubMed ID: 16580422
[TBL] [Abstract][Full Text] [Related]
5. Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy.
Marazzi G; Gebara O; Vitale C; Caminiti G; Wajngarten M; Volterrani M; Ramires JA; Rosano G; Fini M
Adv Ther; 2009 Apr; 26(4):455-61. PubMed ID: 19396409
[TBL] [Abstract][Full Text] [Related]
6. Effects of trimetazidine on endothelial dysfunction after sheath injury of radial artery.
Park KH; Park WJ; Kim MK; Park DW; Park JH; Kim HS; Cho GY
Am J Cardiol; 2010 Jun; 105(12):1723-7. PubMed ID: 20538121
[TBL] [Abstract][Full Text] [Related]
7. [Effects of trimetazidine on serum oxygen free radicals in congestive heart failure].
Ma QL; Xie Y; Zhang SD
Hunan Yi Ke Da Xue Xue Bao; 2002 Dec; 27(6):527-9. PubMed ID: 12658930
[TBL] [Abstract][Full Text] [Related]
8. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
Di Napoli P; Di Giovanni P; Gaeta MA; Taccardi AA; Barsotti A
J Cardiovasc Pharmacol; 2007 Nov; 50(5):585-9. PubMed ID: 18030070
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of trimetazidine treatment on exercise tolerance and B-type natriuretic peptide and troponin T plasma levels in patients with stable ischemic cardiomyopathy.
Di Napoli P; Di Giovanni P; Gaeta MA; D'Apolito G; Barsotti A
Am Heart J; 2007 Sep; 154(3):602.e1-5. PubMed ID: 17719313
[TBL] [Abstract][Full Text] [Related]
10. Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy.
Belardinelli R; Cianci G; Gigli M; Mazzanti M; Lacalaprice F
J Cardiovasc Pharmacol; 2008 Jun; 51(6):611-5. PubMed ID: 18574390
[TBL] [Abstract][Full Text] [Related]
11. Beneficial electrophysiological effects of trimetazidine in patients with postischemic chronic heart failure.
Cera M; Salerno A; Fragasso G; Montanaro C; Gardini C; Marinosci G; Arioli F; Spoladore R; Facchini A; Godino C; Margonato A
J Cardiovasc Pharmacol Ther; 2010 Mar; 15(1):24-30. PubMed ID: 20100903
[TBL] [Abstract][Full Text] [Related]
12. Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study.
Tiano L; Belardinelli R; Carnevali P; Principi F; Seddaiu G; Littarru GP
Eur Heart J; 2007 Sep; 28(18):2249-55. PubMed ID: 17644511
[TBL] [Abstract][Full Text] [Related]
13. Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy.
Tuunanen H; Engblom E; Naum A; Någren K; Scheinin M; Hesse B; Juhani Airaksinen KE; Nuutila P; Iozzo P; Ukkonen H; Opie LH; Knuuti J
Circulation; 2008 Sep; 118(12):1250-8. PubMed ID: 18765391
[TBL] [Abstract][Full Text] [Related]
14. Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease.
Marazzi G; Wajngarten M; Vitale C; Patrizi R; Pelliccia F; Gebara O; Pierri H; Ramires JA; Volterrani M; Fini M; Rosano GM
Int J Cardiol; 2007 Aug; 120(1):79-84. PubMed ID: 17134770
[TBL] [Abstract][Full Text] [Related]
15. The effects of trimetazidine on lipid peroxidation in patients with end-stage renal disease.
Aygen B; Celiker H; Dogukan A; Ilhan N
Methods Find Exp Clin Pharmacol; 2008 Dec; 30(10):757-60. PubMed ID: 19271025
[TBL] [Abstract][Full Text] [Related]
16. Effects of sheath injury and trimetazidine on endothelial dysfunction of radial artery after transradial catheterization.
Park KH; Park DW; Kim MK; Kim HS; Park WJ; Cho GY; Choi YJ
J Interv Cardiol; 2012 Aug; 25(4):411-7. PubMed ID: 22536918
[TBL] [Abstract][Full Text] [Related]
17. [Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease].
Fedorova TA; Il'ina IuV; Sotnikova TI; Rybakova MK
Klin Med (Mosk); 2004; 82(11):15-20. PubMed ID: 15656392
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of trimetazidine on vascular smooth muscle cell and endothelial cell in response to carotid artery balloon injury in diabetic rats.
Yoon JW; Cho BJ; Park HS; Kang SM; Choi SH; Jang HC; Shin H; Lee MJ; Kim YB; Park KS; Lim S
Int J Cardiol; 2013 Jul; 167(1):126-33. PubMed ID: 22240760
[TBL] [Abstract][Full Text] [Related]
19. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
Fragasso G; Perseghin G; De Cobelli F; Esposito A; Palloshi A; Lattuada G; Scifo P; Calori G; Del Maschio A; Margonato A
Eur Heart J; 2006 Apr; 27(8):942-8. PubMed ID: 16510466
[TBL] [Abstract][Full Text] [Related]
20. Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis.
Zhang L; Lu Y; Jiang H; Zhang L; Sun A; Zou Y; Ge J
J Am Coll Cardiol; 2012 Mar; 59(10):913-22. PubMed ID: 22381427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
